My Watchlist for Monday, July 10
( click to enlarge )
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) nice runner from the buy list. This stock continues to show strong momentum and massive accumulation. Looking for a consolidation of the very overbought condition. It should be played with tight stops.
( click to enlarge )
Arca Biopharma Inc (NASDAQ:ABIO) showed buying strength all day on Friday. The stock is on the verge of breaking out and it could happen very soon. The volume dramatically increased last week as the stock ran to near its major resistance, showing me there are a lot of buyers watching the stock. If prices take out the $2.65 resistance or EMA200, then it could rebound strongly towards $3.20-3.40 with a strong chance of testing the 3.60 area. Remember, there is still a huge catalyst coming next month. PR on June 20th "ARCA Biopharma Announces Database Lock for GENETIC-AF Phase 2B Interim Efficacy Analysis – DSMB Recommendation Anticipated in August 2017" i bot a lot of shares on Friday.
( click to enlarge )
Novavax, Inc. (NASDAQ:NVAX) could be getting ready to break out. The OBV indicator shows a marked increase in accumulation since the beginning of the month. The stock is poised to break out of this bullish continuation pattern.
( click to enlarge )
RADA Electronic Ind. Ltd. (NASDAQ:RADA) continued its breakout last week heading from $1.76 to over $2.25 a share on strong money flow. A Buy on dips.
( click to enlarge )
Sounds like Merrimack Pharmaceuticals Inc (NASDAQ:MACK) is gaining some momentum. The stock had a pretty good rebound on price last week accompanied with volume. The chart shows possible new rally as %K line is back above %D line, while the RSI is also gaining strength. The stock needs to break out above $1.51 to go higher. On watch.
( click to enlarge )
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Basing. I would look to the 50-day EMA as the point of resistance. A break of that will send this stock notably higher. Stop 6.06
( click to enlarge )
SUPERVALU INC. (NYSE:SVU) starts showing ‘buy' signals again. It looks like a gap fill candidate to 3.76 area.
( click to enlarge )
RXi Pharmaceuticals Corp (NASDAQ:RXII) was alerted on Friday at 65c on twitter as a potential breakout play. Congrats everyone who took advantage of that. Next week we could see extension of this new momentum towards 85c area.
If you want to contact me for advertising opportunities on blog or twitter, then get in touch via email
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
If you want to contact me for advertising opportunities on blog or twitter, then get in touch via email
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
Labels: ABIO, AUPH, AVEO, MACK, NVAX, RADA, RXII, SVU
